Anavex Life Sciences Corp.
AVXL | NASDAQ
$2.40
-$0.02 (-0.83%)
At close: Sep 21, 2026, 4:00 PM ET
$2.43
+$0.03 (+1.25%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
TTM Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -17.37M | -38.57M | -44.6M | -51.41M | -54.9M | -55.04M | -55.16M | -52.94M | -51.26M | -50.19M | -51.75M | -55.73M | -58.36M | -57.29M | -54.62M | -50.99M | -47.95M | -46.85M | -44.27M | -41.95M | -37.2M | -33.95M | -32.71M |
Interest Income | 999K | 4.21M | 4.36M | 4.68M | 5.44M | 6.16M | 6.71M | 7.32M | 7.52M | 7.55M | 7.26M | 6.52M | 5.27M | 3.67M | 2.21M | 946.99K | 249.56K | 31.09K | 32.73K | 27.82K | 27.65K | 72.29K | 133.25K |
Pretax Income | -13M | -34.1M | -39.93M | -46.38M | -48.29M | -47.27M | -46.62M | -43.13M | -41.59M | -40.62M | -43.13M | -47.5M | -51.37M | -52.41M | -49.76M | -47.62M | -45.12M | -42.98M | -40.7M | -37.64M | -32.02M | -28.36M | -27.47M |
Net Income | -12.99M | -34.09M | -39.95M | -46.38M | -48.17M | -47.14M | -46.49M | -43M | -41.53M | -40.59M | -43.16M | -47.51M | -51.65M | -52.74M | -50.07M | -47.98M | -45.41M | -43.22M | -40.94M | -37.91M | -32.16M | -28.46M | -27.54M |
Selling & General & Admin | 10M | 12.47M | 12.8M | 13.82M | 13.05M | 11.34M | 11.61M | 11.16M | 10.97M | 11.43M | 11.42M | 12.04M | 13.35M | 13.29M | 13.32M | 13.07M | 12.05M | 11.3M | 10.61M | 9.02M | 7.54M | 6.49M | 5.98M |
Research & Development | 20.85M | 26.1M | 31.8M | 37.59M | 41.85M | 43.7M | 43.54M | 41.78M | 40.28M | 38.76M | 39.58M | 42.97M | 44.29M | 43.28M | 41.33M | 37.92M | 35.91M | 35.6M | 33.71M | 32.98M | 29.72M | 27.48M | 26.81M |
Other Expenses | -13.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 750K | 725K | 725K | 725K | -25K | n/a | n/a | -43.28K | -54.1K | -54.1K | -54.1K | -10.82K | -74.94K |
Operating Expenses | 17.37M | 38.57M | 44.6M | 51.41M | 54.9M | 55.04M | 55.16M | 52.94M | 51.26M | 50.19M | 51.75M | 55.73M | 58.36M | 57.29M | 54.62M | 50.99M | 47.95M | 46.85M | 44.27M | 41.95M | 37.2M | 33.95M | 32.71M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 964K | 964K | 964K | 964K | n/a | n/a | n/a | n/a | n/a | 1.56K | 1.56K | 1.56K | 1.56K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.37M | 38.57M | 44.6M | 51.41M | 54.9M | 55.04M | 55.16M | 52.94M | 51.26M | 50.19M | 51.75M | 55.73M | 58.36M | 57.29M | 54.62M | 50.99M | 47.95M | 46.85M | 44.27M | 41.95M | 37.2M | 33.95M | 32.71M |
Income Tax Expense | -9K | -9K | 18K | n/a | -124K | -124K | -124K | -124K | -63.95K | -22.95K | 27.05K | 7.05K | 281.29K | 328.71K | 308.51K | 358.49K | 290.5K | 241.08K | 238.26K | 267.57K | 133.9K | 99.72K | 72.73K |
Shares Outstanding (Basic) | 91.45M | 92.68M | 89.03M | 85.89M | 85.38M | 85.07M | 84.81M | 84M | 84.54M | 82.46M | 82.08M | 79.79M | 80.88M | 78.3M | 77.98M | 76.91M | 77.44M | 76.25M | 76M | 75.78M | 70.59M | 68.6M | 64.3M |
Shares Outstanding (Diluted) | 91.45M | 92.68M | 89.03M | 85.89M | 85.38M | 85.07M | 84.81M | 84M | 84.54M | 82.46M | 82.08M | 79.79M | 80.88M | 78.3M | 77.98M | 76.91M | 77.44M | 76.25M | 76M | 76M | 70.59M | 68.6M | 64.3M |
EPS (Basic) | -0.15 | -0.39 | -0.46 | -0.54 | -0.57 | -0.55 | -0.55 | -0.51 | -0.50 | -0.50 | -0.54 | -0.61 | -0.67 | -0.69 | -0.66 | -0.63 | -0.59 | -0.57 | -0.55 | -0.53 | -0.47 | -0.44 | -0.44 |
EPS (Diluted) | -0.15 | -0.39 | -0.46 | -0.54 | -0.57 | -0.55 | -0.55 | -0.51 | -0.50 | -0.50 | -0.54 | -0.61 | -0.67 | -0.69 | -0.66 | -0.63 | -0.59 | -0.57 | -0.55 | -0.53 | -0.47 | -0.44 | -0.44 |
EBITDA | -11.9M | -32.94M | -38.87M | -46.79M | -52.05M | -51.82M | -51.55M | -46.6M | -45.06M | -42.22M | -42.16M | -46.53M | -50.4M | -51.44M | -49.76M | -47.62M | -45.12M | -42.98M | -41.51M | -30.66M | -26.59M | -24.56M | -23.31M |
EBIT | -11.9M | -32.94M | -38.87M | -46.79M | -52.05M | -51.82M | -51.55M | -46.6M | -45.06M | -42.22M | -42.16M | -46.53M | -50.4M | -51.44M | -49.76M | -47.62M | -45.12M | -42.98M | -41.51M | -38.79M | -34.72M | -32.68M | -31.44M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.13M | 8.13M | 8.13M | 8.13M |
Add to Watchlist
Select watchlists to add or remove AVXL